On October 20, 2025, DLA Piper held a bootcamp for pre-IPO and growth-stage companies in the biotech and medtech industries in the firm’s New York office. Attended by nearly 100 individuals, the bootcamp covered topics including late-stage financings, paths for going public, financial preparedness, regulatory considerations, compliance issues, intellectual property
Continue Reading DLA Piper hosts bootcamp for biotech and medtech companies
The staff of the Division of Corporation Finance (Corp Fin) of the Securities and Exchange Commission (SEC) has issued new Compliance and Disclosure Interpretations (C&DIs) relating to the clawback disclosures required in an issuer’s annual report on Form 10-K and proxy statement. In addition to the April 11, 2025 issuance
Continue Reading Corp Fin releases new guidance on clawback disclosure requirements
Companies seeking to raise capital through a public offering are encouraged to note the US Securities and Exchange Commission (SEC)’s announcement on March 3, 2025 that the staff of the Division of Corporation Finance (SEC staff) has augmented the accommodations available for entities submitting draft registration statements for nonpublic review
Continue Reading SEC expands confidential review process to facilitate capital formation
